Line 47: | Line 47: | ||
</li> | </li> | ||
<li> | <li> | ||
− | <a href="2016.igem.org/Team:Ionis_Paris/Protocol_2"> | + | <a href="https://2016.igem.org/Team:Ionis_Paris/Protocol_2"> |
<span>Protocol 2 : TAE preparation</span> | <span>Protocol 2 : TAE preparation</span> | ||
Line 75: | Line 75: | ||
</li> | </li> | ||
<li> | <li> | ||
− | <a href="2016.igem.org/Team:Ionis_Paris/Protocol_6"> | + | <a href="https://2016.igem.org/Team:Ionis_Paris/Protocol_6"> |
<span>Protocol 6 : E.Coli dh5a and BL21 transformation via heat shock</span> | <span>Protocol 6 : E.Coli dh5a and BL21 transformation via heat shock</span> | ||
Line 81: | Line 81: | ||
</li> | </li> | ||
<li> | <li> | ||
− | <a href="2016.igem.org/Team:Ionis_Paris/Protocol_7"> | + | <a href="https://2016.igem.org/Team:Ionis_Paris/Protocol_7"> |
<span>Protocol 7 : PCR and PCR purification</span> | <span>Protocol 7 : PCR and PCR purification</span> | ||
Line 93: | Line 93: | ||
</li> | </li> | ||
<li> | <li> | ||
− | <a href="2016.igem.org/Team:Ionis_Paris/Protocol_9"> | + | <a href="https://2016.igem.org/Team:Ionis_Paris/Protocol_9"> |
<span>Protocol 9 : Miniprep</span> | <span>Protocol 9 : Miniprep</span> | ||
Revision as of 13:33, 10 October 2016